$MTRI
Mentari Therapeutics, Inc. Common Stock
XNAS
$13.88
▲+13.73%+$1.68Market open
Why is MTRI up today? It is at $13.88 (+13.73%). See the catalyst behind the move, real-time alerts the moment MTRI spikes, and full due diligence on MTRI — key stats, earnings, dilution and insider activity. Free.
Be first to know when $MTRI makes an unusual move. Create a free account to track $MTRI, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on MTRI from our scanner (live price and day move above). Trading was halted for volatility today, which usually marks a fast, sharp move. Fresh from the SEC: InMed Pharmaceuticals Inc.: Defined terms included below shall have the same meaning as terms defined and included in the Company’s definitive proxy. A material company disclosure like this is often the real catalyst behind a move of this size.
Likely catalystMerger / acquisition agreementPrice $0.0001/shareReverse split plannedStatus pending stockholder approval, from the latest SEC filing. Read it →A share sale has already completed, so that supply is out there. Size not stated in the filing.
Some filings did not state a size, so these are floors.
Recent share offering + active shelf on file — the company raised capital and can raise more
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Adar1 Capital Management, Llc Beneficial Owner (10%) | Bought (open market) | +3K 0.05% of company | added 2.8% | 98K | $35K at $13.10 | Nov 5, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Here is the latest on MTRI from our scanner (live price and day move above). Trading was halted for volatility today, which usually marks a fast, sharp move. Fresh from the SEC: InMed Pharmaceuticals Inc.: Defined terms included below shall have the same meaning as terms defined and included in the Company’s definitive proxy. A material company disclosure like this is often the real catalyst behind a move of this size.
MTRI last traded at $13.88, up 13.73% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The MTRI Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire.
MTRI (Mentari Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $67M.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge MTRI for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$MTRI discussion
Sign in to ask a question or join the discussion.